Founder / co-founder
Shiv Rao
Shiv Rao is identified as a founder or co-founder in the linked Abridge announcement. This establishes a founding role at that source date, rather than a current management appointment.
Explore founderHealthcare / COMPANY INTELLIGENCE
Abridge
AI tools that turn clinical conversations into medical documentation and related workflows.
01 / THE BUSINESS
How Abridge creates value.
AI tools that turn clinical conversations into medical documentation and related workflows. The research questions below focus on what would need to be true for adoption to translate into durable economics.
SectorHealthcare
Research coverageBusiness & founders
Research checkedSep 20, 2026
02 / PEOPLE BEHIND THE COMPANY
Meet the builders.
Selected founders; historical founding roles are distinct from current management positions.
03 / CAPITAL & OWNERSHIP
Follow the financing.
Selected disclosed events, newest first. Announcement values describe that transaction and date; they are not current share prices. Debt, equity and secondary transactions are identified separately.
- Equity
Series E
Disclosed amount$300MDisclosed valuationNot disclosedNamed participants: Andreessen Horowitz · Khosla Ventures
Read the announcement
Explore the named investors.
Names refer to the cited transactions. They do not establish current ownership, ownership percentages, or endorsement of this website.
05 / EDITORIAL ANALYSIS
The opportunity. The open questions.
Our interpretation of the business model and cited sources, not a valuation or a recommendation.
The case to investigate
- Evidence of better access or less administrative work may support payer and employer adoption.
Pressure-test the thesis
- Clinical errors, privacy failures and reimbursement changes can disrupt the business.
- Reported savings may not reproduce across patient populations.
What to watch next
01
How are clinical accuracy, health-system integration costs and realized administrative savings measured?
02
What do the latest original disclosures establish about revenue quality, ownership rights and financing needs?
YOUR RESEARCH WORKSPACE
Keep the questions that matter.
Use this checklist to record what you have investigated. Your notes stay in this browser.
06 / RESEARCH TRAIL
Go straight to the source.
Research checked Sep 20, 2026. Selected public disclosures, not a complete capitalization table or securities-filing search. Missing information is left unconfirmed. No investment availability or IPO date is implied.